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ABSTRACT
OBJECTIVE: To estimate the prevalence and variability of nonadherence to immunosuppressives 
and nonpharmacological treatment across kidney transplantation centers and two health 
access-disparate regions in Brazil. 
METHODS: In a cross-sectional design, a random multistage sample of 1,105 patients was 
included, based on center transplantation activity (low/moderate/high) and region (R1: 
North/Northeast/Mid-West; and R2: South/Southeast). Nonadherence to immunosuppressives 
(implementation phase) was assessed using the Basel Assessment of Adherence to 
Immunosuppressive Medications Scale (BAASIS)©. Self-report questionnaires assessed 
nonadherence to physical activity, smoking cessation, alcohol intake, and appointment keeping. 
We compared regions using the adjusted-χ2 or t-test. 
RESULTS: Most patients were men (58.5%), white (51.4%), and had a mean age of 47.5 (SD = 12.6) 
years. Regarding kidney transplantation centers, 75.9% were from R2 and 38.2% had low activity. 
The patients in R2 were older, white-majority, had more frequently steady partners, and received 
peritoneal dialysis. Nonadherence to immunosuppressives ranged from 11–65.2%; 44.5–90% to 
physical activity; 0–23.7% to appointment keeping; and 0–14% to smoking cessation. The total 
prevalence of nonadherence and by region (R1 versus R2) were: for immunosuppressives, 39.7% 
(44.9% versus 38.1%, p = 0.18); for smoking, 3.9% (1% versus 5%, p < 0.001); for physical activity, 
69.1% (71% versus 69%, p = 0.48); for appointment keeping, 13% (12.7% versus 12%, p = 0.77); and 
for alcohol consumption, 0%.
CONCLUSION: Despite differences among centers and high variability, only the nonadherence 
to smoking cessation was higher in the region with greater access to kidney transplantation. 
We suppose that differences in healthcare access may have been overcome by other positive 
aspects of the post kidney transplantation treatment.
DESCRIPTORS: Patient Nonadherence; Medication Nonadherence; Kidney Transplant; 
Multicenter Study; Health Services Accessibility.
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INTRODUCTION
After kidney transplantation (KT), it is essential that transplant patients, who are 
considered chronically ill, adequately follow the proposed treatment to reduce the risks 
of graft rejection and the progression of existing comorbidities, and the development of 
new ones. KT treatment is complex and involves adherence to immunosuppressives and 
nonpharmacological treatment components (regular physical activity, smoking cessation, 
reducing alcohol intake, and appointment keeping)1–3.
The prevalence of nonadherence to immunosuppressives is 28–67% depending on 
casefinding methods, operational definitions, and measurement tools1,4–6. A seven-fold 
increase in graft failure, as well as a clear association with acute rejection episodes, worse 
graft function, higher morbidity, and higher costs to health systems, have been reported5,6. 
Fewer studies have assessed the adherence to nonpharmacological treatment in KT. The 
reported prevalence of nonadherence to physical activity is 21.8–84%, which is also driven by 
variability in methods7–9. Inadequate physical activity can increase the risk for cardiovascular 
disease, which consequently relates to mortality and lower graft survival9,10. For smoking, 
the prevalence is 2.8–4.0 cases per 100 patients per year7. This behavior is also associated 
with cardiovascular diseases, and smoking cessation is recommended upon the diagnosis 
of chronic kidney disease10. Concerning alcohol consumption, post-transplant abuse is 
associated with poor medication adherence, which may increase the risk of graft loss and 
death11. Another fundamental but rarely studied behavior is the frequency of appointment 
keeping. Ranging from 2.5 to 14.6%, nonadherent patients had a 1.5-fold increased risk of 
acute rejection and a 65% higher chance of graft loss7,12.
The ecological model proposes that adherence to these complex behaviors is a result of 
the interaction of multilevel factors, placing the patient at the center and influenced by 
factors from the healthcare provider/family (micro-), the transplant center (meso-), and 
the health care system (macro-) levels12. Some studies have corroborated this framework 
in transplantation13,14. While most reports have focused on patient-level factors, variables 
related to the micro- and meso-levels have been understudied. Should these factors be 
modifiable, they could be potential targets for interventions. For example, multidisciplinary 
follow-up for KT recipients based on the chronic care model, with continuous assessment 
of adherence as the “5th vital sign” may be cited, as well as the provision of support for 
self-management by health care professionals such as nurses, pharmacists, or physical 
therapists, to decrease nonadherence to immunosuppressives and physical inactivity15,16.
Brazil is a country of continental extension that ranks second in the absolute number 
of KTs worldwide, performed by the largest public transplant program17. However, even 
with a full-coverage healthcare system, there are regional disparities regarding access 
to KT. Examination of the Brazilian Transplant Registry18 revealed two distinct regions 
based on transplant activity: the South/Southeast states with elevated organ donation 
and transplantation; and the Northeast, Mid-West, and North states showing lower 
performances18. Out of the 5,923 KTs performed in Brazil in 2018, 3,111 were performed in 
the Southeast, 1,457 in the South, 1,032 in the Northeast, 245 in the Mid-West, and 78 in the 
North18. Data regarding access to general health services shows the same profile. Access 
to healthcare services has been easier in the South and Southeast states, with a higher 
number of medical appointments and doctors. Greater access is also associated with the 
higher grades of socioeconomic parameters statuses of these regions19,20.
The numbers of KT centers and healthcare professionals’ teams mirror the variations in 
healthcare access, and these altogether are translated in these two profiles based on KT 
activity18. Considering the ecological framework discussed above, access to health care, 
and hence to KT centers, can be considered a meso-level characteristic that influence 
adherence behaviors after receiving a kidney graft12. An improved quality of care provided 
by each KT center may, therefore, result in better clinical outcomes. Then, we believed the 
regional disparities offer a unique opportunity to study their influence on adherence to 
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immunosuppressives and nonpharmacological treatment in KT recipients. Besides, the 
results could enable the design of individualized interventions to reduce the nonadherence 
rate in these settings. 
This study aimed to estimate the prevalence and variability of nonadherence to 
immunosuppressives and nonpharmacological treatment across 20 KT centers and in the 
two health access-disparate regions in Brazil.
METHODS
Design, Sampling, and Setting
This study utilized data from the multicenter ADHERE BRAZIL study (ClinicalTrials.gov on 
10/10/2013, NCT02066935), a cross-sectional study aimed at estimating the prevalence of 
nonadherence to immunosuppressives and nonpharmacological treatment among Brazilian 
transplant populations across different regions with different access to healthcare services. 
The study also included a comprehensive evaluation of factors associated with nonadherence 
in 20 KT centers in Brazil21.
The ADHERE BRAZIL study applied a multistage sampling strategy based on the 
transplantation activity of each center (low, moderate, and high) and the health 
access-disparate regions [Northeast/North/Mid-West (R1) and South/Southeast (R2)]18,21. 
The KT activity was based on a pre-existing classification for heart transplant18 and further 
submitted to a panel of Brazilian transplant nephrologists21. Transplant activity at the center 
level was defined as: low, less than 50 KTs/year; moderate, 50–150 KTs/year; and high, more 
than 150 KTs/year21. For the health access-disparate regions, R1 and R2, we considered the 
number of KTs performed per number of inhabitants during the last ten years18. 
The 20 centers were chosen by convenience; the inclusion criteria involved obtaining 
consent for participation from their coordinators and the performance of at least 10 KTs per 
year over the five years preceding the start of the study (2010–2014)21. The selection of centers 
was also guided to keep a similar epidemiological profile when compared to the country. 
Patients scheduled for regular outpatient visit appointments were randomly selected 
based on the following inclusion criteria: age > 18 years, more than one post-transplant 
year, ability to understand the objectives of the study, and willingness to sign the informed 
consent form. The detailed description of the methodology (sample size, sample strata, 
theoretical framework, etc.) has been previously reported12,21 and adapted from the 
BRIGHT Study.13
Variables and Measurements
The characteristics of the participating centers were assessed through structured 
interviews with their respective coordinators to obtain the following variables: number 
of beds available in the transplant center hospital [small/medium hospital (up to 150 
beds); large hospital (151–500 beds); large specialized hospital (>500 beds)]; satisfaction 
with waiting room structure (yes versus no); patient follow-up by the same healthcare 
professional (yes versus no); multiprofessional team by Brazilian law [yes (doctor + nurse 
+ nutritionist + psychologist + social worker) versus no]; continuous education of the KT 
team (yes versus no); clinical guidelines (yes versus no); clinical research (yes versus no); 
electronic medical records (yes versus no); and waiting room educational activities (yes 
versus no).21 The interview with patients included: satisfaction with the number of health 
professionals (yes versus no); difficulties in accessing the center by public transportation 
(yes versus no); time of medical consultation (15 versus 30 minutes); satisfaction with 
the schedule system of the transplant center (yes versus no); difficulties in scheduling 
appointments (yes versus no); adequacy of the frequency of consultation (yes versus no); 
adequacy of time of consultation(yes versus no)21.
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The sociodemographic characteristics of patients were collected through interviews and 
medical records: age (years), sex (male or female), race (white versus non-white), marital 
status (steady partner versus not), education level [illiterate (0–4 years), elementary school 
(4–8 years), high school (> 8 to 11 years), college (> 11 years)], religion (Catholic, Protestant, 
Other), employment (active work versus no active work), and family income (up to 1 reference 
wage, > 1 to 3 wages, > 3 to 5 wages, more than 5 wages). Clinical data were collected 
by medical record review: pre-transplantation treatment time (months), pre-transplant 
treatment modality (hemodialysis, peritoneal dialysis, preemptive), donor type (living 
versus deceased donor), post-transplant time (years), latest creatinine levels, and episodes 
of acute rejection (yes versus no)6,13,21.
For the diagnosis of nonadherence to immunosuppressives, the implementation phase of 
medication adherence was evaluated using the Brazilian Portuguese validated version of 
the Basel Assessment of Adherence with Immunosuppressive Medication Scale (BAASIS)©22. 
This self-report questionnaire is composed of four dimensions frequently associated with the 
failure of the implementation phase (taking and timing adherence, drug holidays, and dose 
reduction). Patients who reported any deviation in any of the items within the preceding 
four weeks were considered nonadherent22.
Nonadherence to nonpharmacological treatment components (physical activity, smoking 
cessation, alcohol consumption, and appointment keeping) was evaluated through the 
patient interview during routine office consultations21. A patient who performed less than 
150 minutes of activity per week was considered nonadherent to the physical activity 
recommendations23. For smoking, we considered nonadherent those who consumed 
cigarettes during the data collection period24. nonadherence to alcohol ingestion was 
a daily alcohol consumption of one drink for women and two for men25. Regarding the 
frequency of consultations, we defined nonadherence as missing more than one of the last 
five scheduled appointments21.
Data Collection
Data were collected from December 2015 to April 2017 during routine consultations 
in the transplantation service through the Research Electronic Data Capture system, 
a secure internet program that stores data and can be remotely powered by trained 
personnel23. All coordinators were trained to use the system for the data collection. 
Patients scheduled for consultation wererandomly selected by a computerized method, 
and those who were eligible would receive information about the ADHERE study to provide 
written consent21.
Statistical Analysis
Categorical variables were described by frequency and percentage, while continuous 
variables by central tendency and dispersion measure, where appropriate.
Because the sample was designed to be self-adjusted21, the comparisons between regions 
(R1 and R2) in nonadherence to immunosuppressives and nonpharmacological treatment 
components (in terms of centers, demographics, and clinical data) were analyzed using the 
adjusted χ2 test or t-test. All variables are presented with their respective 95% confidence 
intervals (95%CI). The analyses were performed using STATA version 14 (StataCorp LP, 
College Station, TX, USA).
Ethical Considerations
The study was approved by the Ethics Committee of the University Hospital of the 
Universidade Federal de Juiz de Fora (691,120) and registered nationally (CAAE 
27972914.1.1001.5133). Participating centers also submitted the protocol for approval 
by their local ethics committee. All patients signed informed consent forms before 
data collection.
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Figure 1. Flowchart of enrolment of KT patients. KT – kidney transplant.
5,785 patients screened 
1,763 patients randomly selected
116 Pre-selected patients did not 
fill inclusion criteria (18 years old; 
>1 year post KT)
1,647 eligible
(Filled the inclusion criteria) 
542 patients did not participate 
296 Operational issues 
143 Refusal
103 Absence
Final sample 1,105 patients















Number of beds of the transplant center hospital
Small/medium hospital (till 150 beds) 7.8 (86) 1.92–26.6 7.5 (20) 5.7–53.1 7.9 (66) 1.4–32.4 0.26
Large hospital (151 to 500 beds) 53.6 (592) 26.9–78.2 81.0 (216) 31.8–97.4 44.9 (376) 26.9–78.2
Special large hospital: > 500 beds 38.6 (427) 17.0–65.8 11.6 (31) 9.1–65.2 47.3 (396) 16–77.5
Multiprofessional team, Brazilian law Doctor+ 
nurse + nutritionist + psychologist + social 
worker (yes)
80.1 (886) 50.8–94 92.5 (247) 46.8–99.4 76.2 (639) 41.0–93.6 0.59
Clinical guidelines (yes) 94.0 (1039) 74.9–98.8 100.0 (267) 100.0 92.1 (772) 67.5–98.5 0.48
Continuous education directed to KT team (yes) 97.7 (1080) 82.0–99.7 100.0 (267) 100.0 97.0 (813) 76.6–99.6 0.61
Electronic medical records (yes) 53.8 (595) 25.6–79.7 29.6 (79) 4.8–77.5 61.6 (516) 25.0–88.5 0.28
Waiting room educational activities (yes) 47.9 (529) 21.3–75.6 57.7 (154) 12.6 – 92.7 44.7 (375) 16.0–77.4 0.68
Not satisfied with waiting room structure* (yes) 42.7 (427) 32.7–53.4 71.9 (192)* 54.6 – 84.4 33.4 (280)* 25.3–42.7 0.005
Not satisfied with the number of health 
professionals* (yes)
44.6 (493) 44.9–64.9 61.0 (163)* 52.2 – 69.2 39.6 (330)* 27.4–53.1 0.01
Difficulties in accessing the center by public 
transportation (yes)
13.7 (152) 6.2–27.9 13.8 (37) 6.2 – 27.9 13.7 (115) 6.3–27.2 0.69
Average total time of medical consultation 
15 minutes 31.4 (348) 12.9–58.7 27.3 (73) 3.8–78.1 32.8 (257) 11.6–64.3 0.83
30 minutes 68.5 (757) 41.2–87.0 72.6 (194) 21.8–96.2 67.1 (563) 35.6–88.3
Not satisfied with the schedule system of the 
transplant center (yes)
22.9 (253) 13.9–35.4 31.2 (83) 19.0–46.6 20.3 (170) 9.6–37.9 0.27
Difficulties in scheduling appointments (yes) 10.3 (114) 6.2–16.8 16.2 (43) 6.4–35.4 8.5 (71) 4.3–16.1 0.23
Adequacy of the frequency of consultation* (yes) 86.4 (955) 83.0–89.5 87.9 (234)* 81.3–92.4 86.1 (721)* 81.9–89.5 0.02
Adequacy of time of consultation (yes) 94.8 (1,046) 93.1–96.1 93.2 (248) 89.2–95.8 95.3 (798) 93.6–96.6 0.18
Health system
Private insurance 23.4 (259) 19.3–28.0 18.7 (50) 12.3–27.3 24.9 (209) 20.4–30.0 0.18
Lab exams by public health system 90.3 (997) 83.6–94.5 83.5 (223) 75.8–89.1 92.6 (744) 84.5–96.2 0.06
Refill of immunosuppressives in another city 45.8 (506) 38.4–53.4 52.2 (139) 42.1–62.2 43.7 (367) 34.8–53.2 0.12
Immunosuppressives refill in a distant place* 54.0 (596) 46.3–61.5 66.9 (178) 62.9–70.6 49.9 (418) 40.5–59.3 0.002
Data are shown in mean + standard deviation or frequencies.
* We compare regions N/NE/MW (R1) versus South/Southwest (R2) by adjusted Chi-square test/95%CI or t test.
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RESULTS
Sample Characteristics (Centers and Patients)
At the 20 participating centers, 5,785 patients were screened. Of them, we randomly 
selected 1,763 patients; and from these, 1,647 met the inclusion criteria. We finally 
included 1,105 patients (participation rate, 67%). The remaining were excluded due to 
operational issues (n = 296), refusal for participation (n = 143), and nonattendance to the 
consultations (n = 103) (Figure 1).
Most centers of the ADHERE Brazil study (n = 17; 85%) were of low or moderate KT activity 
and located in large hospitals (53.6%). Dissatisfaction with the waiting room structure 















Male 58.5 (647) 54.2–62.7 53.5 (143) 45.5–61.3 60.1 (504) 56.0–64.0 0.13
Race 
White* 51.4 (586) 41.1–61.5 23.6 (63) 16.6–32.3 60.2 (505) 46.2–72.8 0.001
Age (years) 47.5 ± 12.6 – 44.1 ± 13.1 – 48.6 ± 12.2 – 0.001
Education level
Illiterate (0–4y) 7,8 (86) 4.9–12.0 6.3 (17) 3.2–12.0 8.2 (69) 4.7–13.9 0.15
Elementary school (4–8 years) 39.0 (431) 35.4–42.7 32.2 (86) 24.1–41.6 41.4 (345) 36.9–45.5
High school (> 8 to 11 years) 38.3 (423) 33.9–42.8 43.0 (115) 35.9–50.4 36.7 (308) 31.1–42.7
College (< 11 years) 14,9 (165) 12.3–17.9 18.3 (49) 15.2–22 13.8 (116) 10.8–17.5
Marital Status 
Stable partner* 60.0 (662) 56.3–63.5 54.3 (144) 48.0–60.5 61.8 (518) 57.8–65.6 0.04
Not employed* 76.7 (848) 73.3–79.8 81.6 (218) 76.9–85.5 75.1 (630) 71.3–78.6 0.03
Family income
Until 1 reference wage 25.4 (281) 19.2–32.8 33.0 (88) 23.1 – 44.4 23.0 (193) 16.6–31.0 0.16
> 1 to 3 wages 52.7 (582) 46.4–58.8 50.9 (134) 43.3–57 53.5 (448) 45.8–61.0
> 3 to 5 wages 14.2 (157) 11.4–17.5 9.7 (26) 5.2–17.4 15.6 (131) 13.0–18.6
Up to 5 wages 7.6 (84) 4.9–11.4 7.1 (19) 4.8–10.3 7.7 (65) 4.5–13.0
Religion
Catholic 63.6 (703) 60.6–66.5 68.5 (183) 65.5–71.3 62.0 (520) 58.4–65.5 0.45
Protestant 26.0 (287) 23.3–28.7 24.3 (65) 19.2–30.2 26.4 (222) 23.3–29.8
Other 10.5 (116) 1.0–3.6 7.2 (19) 1.0–11.1 11.4 (96) 1.2–3.8
Pre-KT treatment* 93.0 (1028) 91.3–94.4 97.0 (259) 95.1–98.1 91.8 (769) 89.7–93.3 0.05
 Hemodialysis 3.7 (40) 2.4–5.2 1.9 (5) 0.7–5.1 4.2 (35) 2.9–5.9
 Peritoneal dialysis 3.3 (37) 2.2–5.1 1.1 (3) 0.3–4.3 4.0 (34) 2.5–6.4
 Preemptive
Pre-transplantation treatment time (months) 40.4 ± 40.4 – 42.7 ± 39.8 – 39.6 ± 40.5 – 0.13
Post-transplant time (years) 6.2 ± 4.8 – 6.0 ± 4.9 – 6.2 ± 4.7 – 0.77
Type of donor
Deceased 65.2 (721) 55.8–73.5 72.2 (193) 54.2–85.1 63.0 (528) 52.9–72.1 0.32
Acute rejection
Yes 22.8 (2) 17.4–29.3 19.4 (52) 15.1–24.6 23.9 (198) 17.1–32.2 0.29
Last creatinine* 1.6 ± 0.83 – 1.4 ± 0.78 – 1.6 ± 0.84 – 0.001
Data are shown in mean + standard deviation or frequencies. 
* We compare regions N/NE/MW (R1) versus South/Southwest (R2) by adjusted Chi-square test/
95%CI or t test.
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was frequently reported (42.7%). It was higher in R1 (71.9% versus 33.4%, p = 0.005), as was 
dissatisfaction with the number of health professionals (overall, 44.6%; 61% versus 39.6%, 
p = 0.01). The overall rate of consultation frequency adequacy was very high (86.4%), and this 
was higher in R1 (87.9 versus 86.1%, p = 0.02). The facility of immunosuppressives dispensing 
was considered too distant for most patients, mainly in R1 (66.9 versus 49.9%, p = 0.002). 
However,  the vast majority underwent their laboratory examinations in public health 
system facilities (90.3%), more frequently in R2 than in R1 (92.6 versus 83.5%, respectively). 
Other variables were similar between regions (Table 1).
Fifty-eight percent of patients were 58.5% male (53.5% in R1 versus 60.1% in R2). Most of 
them self-declared as white (overall, 51.4%; 23.6 versus 60.2%). In R2, the patients were older 
than those in R1 (48.6 [SD = 12.2] versus 44.1 [SD = 13.1] years, respectively). Regarding 
education level, 39% had 4–8 years of schooling (32.2% in R1 versus 41.4% in R2). Ninety-
three percent underwent hemodialysis before transplantation (97.0% in R1 versus 91.8% in 
R2), and 65.2% received a deceased donor graft in all regions. The mean overall creatinine 
level was 1.6 [SD = 0.83 mg/dL (1.4 [SD = 0.78 mg/dL] in R1 versus 1.6[SD = 0.84 mg/dL] 
in R2) (Table 2).
Prevalence of nonadherence to immunosuppressives and health behaviors
The overall prevalence of nonadherence to immunosuppressives was 39.7% (range, 11.0–65.2%) 
among KT centers (Figure 2). When evaluating nonadherence to immunosuppressives by 
the four separate dimensions of the BAASIS© (taking and timing, drug holidays, and dose 
reduction), the highest prevalence in the sample was in the deviations in timing (30.6%), 
followed by nonadherence to immunosuppressives intake (14.3%), drug holiday (6.0%), and 
dose reduction (5.4%) (Figure 3). 
Figure 2. Nonadherence to immunosuppressives (2A) and nonpharmacological treatment (2B: physical activity recommendations, 2C: 
scheduled appointments and, 2D: smoking cessation) in the total sample (dotted line), at each center (numbers in horizontal axis) and in 
health access-disparate regions. R1 = Northeast/North/Mid-West (green) and R2 = South/Southwest (orange). We compared the R1 versus 
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Regarding nonpharmacological treatment components, the highest prevalence of 
nonadherence was to physical activity recommendations (less than 150 min/week), 
accounting for 69.1% (range, 44.5–90%). Nonattendance of at least one of the last five 
scheduled appointments was 12.7% (0–23.7%). Only 3.9% (0–13.9%) were current smokers, 
and all participants denied being heavy drinkers (Figure 2). 
Comparing regions and the prevalence of nonadherence to nonpharmacological treatment, 
only nonadherence to smoking cessation was more frequent in the R1 region (5% versus 
1%; p < 0.001) (Figure 2).
DISCUSSION 
This was the first multicenter study of KT patients to evaluate adherence to different health 
behaviors in Brazil. It is also the first study elucidating a panel of these risky behaviors in a 
variety of KT centers across the two health access-disparate regions of Brazil. We deemed 
the large sample size as one of the strengths of our study, alongside the sample design that 
aimed to approximately represent the Brazilian KT population, and the use of a theoretical 
framework, i.e., the ecological model12, to select potential multilevel correlates, which is 
uncommon in existing adherence studies.
The studied sample has demographic characteristics that ref lect the KT population 
worldwide – age, male sex, deceased-donor type, and hemodialysis as previous treatment. 
We found that the schooling level and family income represented a specific epidemiological 
frame, particularly of a low socioeconomic level population. Furthermore, for the first time, 
some aspects of the clinical practice of KT centers have been analyzed and compared based 
Figure 3. Implementation nonadherence to immunosuppressives by BAASIS© scale dimensions [taking (2A), timing (2B), drug holidays 
(2C) and dose reduction (2D)] in total sample (dotted line), at each center (numbers in horizontal axis) and in health access-disparate 
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on two healthcare access-disparate regions in Brazil. The higher dissatisfaction with the 
waiting room structure and with the number of health professionals reported by patients 
from R1, which supposedly had worse access, reinforced the hypothesis of limited health 
care availability, such as the greater distance to immunosuppressives dispensing facilities. 
The highest frequency of nonadherence after KT in the entire sample and the studied 
regions was to physical activity. In one center, 90% of patients were physically inactive. 
Despite being understudied, the nonadherence to post-KT physical activity was estimated 
at 35–84%8,26,27, similar to what we found in our study. Physical activity helps prevent 
cardiovascular diseases, which is the major cause of post-transplant death and improves 
the quality of life28. Although physical activity promotion programs have improved some 
aspects of physical performance, the evidence for their effects on graft outcomes is lacking. 
Therefore, physical activity programs are a promising area of research28.
The second highest prevalence of nonadherence was to immunosuppressives. We found a 
total prevalence of 39.7%, similar to the previously reported 20–60%1,4,5, using self-report 
instruments for diagnosis. Interestingly, we found some effect, with the additional 7 points 
in the prevalence of R1 and a p-value of 0.18, nonadherence to immunosuppressives was 
similar in the two health access-disparate regions. There are currently no data on access 
to healthcare services for KT in Brazil. The universal access to health services provided 
by our public health system is challenged in some low socioeconomic level areas, which is 
reflected by the smaller number of consultations and health professionals29. The treatment 
of chronic kidney disease in its more advanced phase, — dialysis and transplantation— 
is classified as highly complex, has differentiated reimbursement, and is often provided 
by a well-organized center/hospital. Thus, after KT, the patient has the opportunity 
to be followed in such a structured service, surpassing the other failures of the health 
system. However, we found no association between R1 and R2 in terms of the four BAASIS 
dimensions (immunosuppressives taking and timing, drug holidays, and dose reduction). 
Further studies, applying different methodologies to categorize health access, such as the 
five geographic regions or the human development index, could better explore this finding.
We found a high prevalence of patients not keeping their appointments for KT services 
(12.7%). This figure varied widely among centers but not between the studied regions. This 
prevalence is one of the highest among the few available studies5,11. Strategies for decreasing 
nonattendance are feasible and could prevent this behavior, which is ultimately associated 
with graft loss11.
Nonadherence to smoking cessation was similar to that described by other KT studies, 
but this behavior was only one more frequent in R2. The highest nonadherence rate among 
services was 13.9%. In this case, the higher prevalence of smokers in the R2 region can be 
attributed to the relatively better economic status of patients, favoring access to cigarettes30. 
Smoking is associated with an increased risk of cardiovascular death and a 50% greater 
risk of graft loss when compared to ex-smokers. These findings suggest the need for greater 
emphasis on smoking cessation, even in the pre-transplantation period9. 
Alcohol dependence in the pre-transplantation phase is associated with a 38% increased 
risk of graft loss due to death and a 56% increased risk of transplant-related death10. None 
of the studied KT patients reported the use of alcoholic beverages. The methodological rigor 
used to define this NAd behavior may have influenced these results25.
The prevalence of nonadherence to treatment dimensions reported in the KT population 
supports that services include specif ic interventions to encourage adherence to 
immunosuppressives and to relevant nonpharmacological treatment components such as 
physical activity and smoking cessation. KT centers should also emphasize the importance 
of attendance to consultations for controlling the current health condition7,9,10. Evidence 
of interventions to reduce nonadherence is limited, but studies suggest that efficient 
measures should be multidimensional and involve a multiprofessional team (doctors, nurses, 
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pharmaceutics, psychologists, nutritionists, social assistants). Strategies for assessing 
specific individual barriers and developing measures that could be integrated into daily 
life have also been proposed. These personalized care interventions directed to improve 
self-care management, reinforce self-monitoring and self-efficacy and have the potential 
to improve adherence to all aspects of treatment included in our study15,16.
The first limitation of this study is that the cross-sectional design did not allow for causal 
inferences. Second, the 20 participating centers were selected by convenience to ensure 
economic viability and minimize data loss. In the attempts to avoid selection biases, 
patients were selected randomly for inclusion, but we only screened those with scheduled 
appointments during the data collection period. Finally, we diagnosed nonadherence using 
a self-report method, which may have led to underestimation in results22.
CONCLUSION
In this large-sample study, which approached to be representative of the Brazilian KT 
population, there was an overall high prevalence of nonadherence to immunosuppressives 
and to nonpharmacological treatment (physical activity, smoking cessation, and keeping 
appointments). Differences were found among clinical practices in the two health access-
disparate regions, while only nonadherence to smoking cessation occurred more frequently 
in the R2 region. We propose that the quality of healthcare during follow-up surpassed the 
limitations in healthcare facilities, which could have potentially influenced the prevalence 
of nonadherence among KT patients. Nonetheless, transplant service professionals should 
consider seeking interventions to reduce nonadherence since they may negatively impact 
post-transplant outcomes.
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